药品注册申请号:070299
申请类型:ANDA (仿制药申请)
申请人:HIKMA
申请人全名:HIKMA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 NALOXONE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML No No AP 1985/10/22 1986/09/24 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2015/03/12 SUPPL-17(补充) Approval Labeling STANDARD
2000/09/14 SUPPL-16(补充) Approval Manufacturing (CMC)
1999/01/25 SUPPL-15(补充) Approval Manufacturing (CMC)
1999/01/25 SUPPL-14(补充) Approval Manufacturing (CMC)
1997/09/26 SUPPL-13(补充) Approval Manufacturing (CMC)
1996/08/26 SUPPL-12(补充) Approval Manufacturing (CMC)
1993/11/18 SUPPL-11(补充) Approval Manufacturing (CMC)
1993/07/27 SUPPL-10(补充) Approval Manufacturing (CMC)
1993/03/26 SUPPL-9(补充) Approval Labeling
1990/09/25 SUPPL-7(补充) Approval Labeling
1990/02/22 SUPPL-6(补充) Approval Labeling
1989/07/20 SUPPL-5(补充) Approval Labeling
1987/01/29 SUPPL-2(补充) Approval Manufacturing (CMC)
1987/01/29 SUPPL-1(补充) Approval Manufacturing (CMC)
1986/12/19 SUPPL-4(补充) Approval Manufacturing (CMC)
1986/11/03 SUPPL-3(补充) Approval Manufacturing (CMC)
1985/10/22 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:NALOXONE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:0.4MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
070299 001 ANDA NALOXONE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 1986/09/24 HIKMA
070172 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No Yes AP 1986/09/24 HOSPIRA
070256 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No Yes AP 1987/01/07 HOSPIRA
070257 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No Yes AP 1987/01/07 HOSPIRA
204997 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2014/03/06 MYLAN INSTITUTIONAL
205014 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2016/06/29 MYLAN INSTITUTIONAL
208871 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2017/02/28 RISING
208872 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2017/03/14 RISING
207634 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2017/07/26 SOMERSET THERAPS LLC
207633 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2017/08/08 SOMERSET THERAPS LLC
212455 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Discontinued No No AP 2019/10/15 EUGIA PHARMA
212456 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2019/11/04 EUGIA PHARMA
214785 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2021/01/29 BAXTER HLTHCARE CORP
216624 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2022/10/26 ACCORD HLTHCARE
214792 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2022/11/07 BAXTER HLTHCARE CORP
218404 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2024/02/29 MANKIND PHARMA
212300 002 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2024/03/07 HIKMA
213573 001 ANDA NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTABLE;INJECTION 0.4MG/ML Prescription No No AP 2024/04/02 FRESENIUS KABI USA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database